The randomized, double-blind, double-dummy, active controlled study1 results suggested that Benolea reduces total cholesterol and plasma triglyceride levels in a.
In the trial, Benolea and Captopril had lowered systolic and diastolic blood pressure compared to baseline.
The reduction of blood pressure in the natural treatment group with Benolea was comparable to the pharmaceutical group with Captopril.
With regards to lipid profile, Benolea reduced total cholesterol and triglyceride levels in participants with high baseline triglyceride levels, the reduction was remarkable: the triglycerides diminished by 53.13 mg/dl.
In summary, the results of this clinical study show that the olive leaf extract has similar blood pressure reducing effects in people with mild elevated values as a standard anti-hypertensive drug.
Benolea also positively influences the lipid profile of this population, and is safe and well-tolerated.